扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  关于我们  联系我们
产品中心-北京博奥森生物技术有限公司
Recombinant Human SERPINA3 Protein, C-His (bs-104651P)  
订购热线:400-901-9800
订购邮箱:sales@bioss.com.cn
订购QQ:  400-901-9800
技术支持:techsupport@bioss.com.cn
20ug/980.00元
50ug/1880.00元
100ug/2680.00元
大包装/询价
产品编号 bs-104651P
英文名称 Recombinant Human SERPINA3 Protein, C-His
中文名称
别    名 Cell growth-inhibiting gene 24/25 protein; ACT; Serpin A3; Alpha-1-antichymotrypsin; SERPINA3; AACT  
克 隆 号
理论分子量 47 kDa
性    状 Lyophilized
纯    度 >90% as determined by SDS-PAGE.
缓 冲 液 Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
保存条件 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Alpha 1-Antichymotrypsin, a member of the serine proteinase inhibitor (serpin) family, inhibits neutrophil proteinase cathepsin G and mast cell chymases, and protects the lower respiratory tract from damage by proteolytic enzymes. It contains a reactive centre loop, which interacts with cognate proteinases, resulting in loop cleavage and a major conformational change. Recently, alpha 1-antichymotrypsin has been identified as a major constituent of the neurofibrillary plaques associated with Alzheimers disease, and in vitro studies have shown that it enhances the rate of amyloid-fibril formation. These observations and recent genetic evidence suggest that alpha 1-antichymotrypsin is important in the pathogenesis of Alzheimers disease.

SWISS:
P01011

Gene ID:
12

AACT是由神经胶质细胞分泌并参与淀粉样纤维生成和沉积的一种色氨酸蛋白酶抑制剂,被认为是Aβ肽的假性底物,与Aβ肽具有很高的亲合性,可促进Aβ肽的纤维化以生成淀粉样沉积。 ApoE作为AD的另一种病理伴随性物质,也可识别并与Aβ肽相结合,促进Aβ肽沉积生成淀粉样老年斑块。由于AACT和ApoE在AD发病中具有共同的作用途径,因此探讨其相互作用可能是AD治疗中一个新的途径。 AACT是一种丝氨酸蛋白酶抑制剂,可以中和糜蛋白酶等酶活性的蛋白酶,存在于大多数的组织细胞、巨噬细胞以及多种胃肠道和肺部肿瘤中,但多形
版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022     证书编号: CQC24QY20047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号